Browse by Audience
Skip to content
Novel disease-modifying treatments for neuropathic pain are urgently required. The cellular immune response to nerve injury represents a promising target for therapeutic development. Recently, the role of natural killer (NK) […]
Learn More >Osteoarthritis (OA) drug development is hampered by a number of challenges. One of the main challenges is the apparent discordance between pain and structure, which has had a significant impact […]
Learn More >The Academy of Orthopedic Physical Therapy (AOPT) Pain Education Manual (PEM) supports the advancement of modern pain content, and the National Institutes of Health Federal Pain Research Strategy (FPRS) has […]
Learn More >
Why a distinct medical stream is necessary to support patients using cannabis for medical purposes.
Since 2001, Canadians have been able to obtain cannabis for medical purposes, initially through the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Cannabis Act (Bill C-45) came into […]
Learn More >